HU-331: A cannabinoid quinone, with uncommon cytotoxic properties and low toxicity

Maximilian Peters, Natalya M. Kogan*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations

Abstract

The oxidation of cannabis constituents has given rise to their corresponding quinones, which have been identified as cytotoxic agents. Out of these molecules the quinone of cannabidiol - the most abundant non-psychoactive cannabinoid in Cannabis sativa - has shown the highest cytotoxicity. This compound was named HU-331 and it exerts antiangiogenic properties, induces apoptosis to endothelial cells and inhibits topoisomerase II in nanomolar concentrations. Unlike other quinones, it is not cardiotoxic and does not induce the formation of free radicals. A comparative in vivo study in mice has shown HU-331 to be less toxic and more effective than the commonly used doxorubicin. This review summarises the properties of HU-331 and compares it with doxorubicin and other topoisomerase II inhibitors.

Original languageAmerican English
Pages (from-to)1405-1413
Number of pages9
JournalExpert Opinion on Investigational Drugs
Volume16
Issue number9
DOIs
StatePublished - Sep 2007

Keywords

  • Antiangiogenesis
  • Apoptosis
  • Cannabinoid
  • Cardiotoxicity
  • Preclinical study
  • Quinone
  • Topoisomerase II

Fingerprint

Dive into the research topics of 'HU-331: A cannabinoid quinone, with uncommon cytotoxic properties and low toxicity'. Together they form a unique fingerprint.

Cite this